Targeting Selectins and Their Ligands in Cancer

Aberrant glycosylation is a hallmark of cancer cells with increased evidence pointing to a role in tumor progression. In particular, aberrant sialylation of glycoproteins and glycolipids has been linked to increased immune cell evasion, drug evasion, drug resistance, tumor invasiveness, and vascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Natoni, Alessandro, Macauley, Matthew S., O’Dwyer, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834419/
https://www.ncbi.nlm.nih.gov/pubmed/27148485
http://dx.doi.org/10.3389/fonc.2016.00093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834419/
https://www.ncbi.nlm.nih.gov/pubmed/27148485
http://dx.doi.org/10.3389/fonc.2016.00093

Ejemplares similares